BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26834627)

  • 1. Expression of Alzheimer-Type Neurofibrillary Epitopes in Primary Rat Cortical Neurons Following Infection with Enterococcus faecalis.
    Underly R; Song MS; Dunbar GL; Weaver CL
    Front Aging Neurosci; 2015; 7():259. PubMed ID: 26834627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
    Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
    Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
    Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
    J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease.
    Luna-Muñoz J; Chávez-Macías L; García-Sierra F; Mena R
    J Alzheimers Dis; 2007 Dec; 12(4):365-75. PubMed ID: 18198423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alz-50 recognizes a phosphorylated epitope of tau protein.
    Uéda K; Masliah E; Saitoh T; Bakalis SL; Scoble H; Kosik KS
    J Neurosci; 1990 Oct; 10(10):3295-304. PubMed ID: 1698946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The monoclonal antibody, Alz 50, recognizes tau proteins in Alzheimer's disease brain.
    Nukina N; Kosik KS; Selkoe DJ
    Neurosci Lett; 1988 May; 87(3):240-6. PubMed ID: 3132653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional conformational change involving phosphorylation of tau protein at the Thr231, precedes the structural change detected by Alz-50 antibody in Alzheimer's disease.
    Luna-Muñoz J; García-Sierra F; Falcón V; Menéndez I; Chávez-Macías L; Mena R
    J Alzheimers Dis; 2005 Sep; 8(1):29-41. PubMed ID: 16155347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of microtubule stabilization and destabilization on tau immunoreactivity in cultured hippocampal neurons.
    Mattson MP
    Brain Res; 1992 Jun; 582(1):107-18. PubMed ID: 1354011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.
    Kondratick CM; Vandré DD
    J Neurochem; 1996 Dec; 67(6):2405-16. PubMed ID: 8931473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive Alzheimer's-type tau epitopes in a neuritogenic rat CNS cell line.
    Lambert MP; Sabo S; Zhang C; Enam SA; Klein WL
    Neurobiol Aging; 1995; 16(4):583-9. PubMed ID: 8544909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.
    Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA
    Acta Neuropathol; 2010 Jul; 120(1):13-20. PubMed ID: 20532897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.
    Combs B; Hamel C; Kanaan NM
    Neurobiol Dis; 2016 Oct; 94():18-31. PubMed ID: 27260838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain.
    Vincent I; Jicha G; Rosado M; Dickson DW
    J Neurosci; 1997 May; 17(10):3588-98. PubMed ID: 9133382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical evidence for reorganization of tau in the plaques and tangles in Alzheimer's disease.
    Wood JG; Zinsmeister P
    Histochem J; 1989 Nov; 21(11):659-62. PubMed ID: 2511165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
    Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
    Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's neurofibrillary tangles contain unique epitopes and epitopes in common with the heat-stable microtubule associated proteins tau and MAP2.
    Yen SH; Dickson DW; Crowe A; Butler M; Shelanski ML
    Am J Pathol; 1987 Jan; 126(1):81-91. PubMed ID: 2433949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau Positive Neurons Show Marked Mitochondrial Loss and Nuclear Degradation in Alzheimer's Disease.
    Wee M; Chegini F; Power JHT; Majd S
    Curr Alzheimer Res; 2018; 15(10):928-937. PubMed ID: 29895248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.